Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models

Vaccine

Volumn 29, Issue 4, 2011, Pages 636-643

  Xu, Xin Gang ^a   Wang, Zhi Sheng ^a   Zhang, Qi ^a   Li, Zhao Cai ^a   Zhao, Hong Ni ^a   Li, Wei ^a   Tong, De Wen ^a   Liu, Hung Jen ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Baculovirus surface display; E glycoprotein; Japanese encephalitis virus

Indexed keywords

BACULOVIRUS SURFACE E ENVELOPE VACCINE; GLYCOPROTEIN E; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; SA14 14 2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACULOVIRUS; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; DRUG MECHANISM; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOGOLD ELECTRON MICROSCOPY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; VACCINATION; VIRUS INFECTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELL PROLIFERATION; DRUG CARRIERS; ENCEPHALITIS VIRUS, JAPANESE; FEMALE; GENETIC VECTORS; JAPANESE ENCEPHALITIS VACCINES; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SWINE; VACCINATION; VIRAL ENVELOPE PROTEINS;

EID: 78650569189     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.045     Document Type: Article

References (35)

1. Shope R.E. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. The togaviruses 1980, 47-82. Academic Press, New York. R.W. Schlesinger (Ed.).
2. Monath T.P., Heinz F.X. Flaviviruses. Fields virology 1996, 961-1034. Lippincott-Raven Publishers, Philadelphia. 3rd ed. N. Fields, D.M. Knipe, P.M. Howley (Eds.).
3. Kuno G., Chang G.J., Tsuchia K.R., Karabatsos N., Cropp C.B. Phylogeny of the genus flavivirus. J Virol 1998, 72:73-83.
4. Lin C.W., Wu S.C. A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining site. J Virol 2003, 77:2600-2606.
5. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Lnnis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319:608-614.
6. Xin Y.Y., Ming Z.G., Peng G.Y., Jian A., Min L.H. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 1988, 39:214-217.
7. Tsai T.F., Chang G.J.J., Yu Y.X. Japanese encephalitis vaccines. Vaccines 1999, 672-710. WB Saunders, Philadelphia. 3rd ed. S.A. Plotkin, W.A. Orenstein (Eds.).
8. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. New Engl J Med 1988, 319:608-614.
9. Hennessey S., Liu Z., Tsai T.F., Strom B.L., Wan C.M., Liu H.L., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine [SA14-14-2]: a case-control study. Lancet 1996, 347:1583-1586.
10. Nothdurft H.D., Jelinek T., Marschang A., Maiwald H., Kapaun A., Loscher T. Adverse reactions to Japanese encephalitis vaccine in travellers. J Infect 1996, 32:119-122.
11. Poland J.D., Cropp C.B., Craven R.B., Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990, 161:878-882.
12. Juang R.F., Okuno Y., Fukunaga T., Tadano M., Fukai K., Baba K., et al. Neutralizing antibody responses to Japanese encephalitis vaccine in children. Biken J 1983, 26:25-34.
13. Monsma S.A., Oomens A.G.P., Blissard G.W. The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection. J Virol 1996, 70:4607-4616.
14. Kitagawa Y., Tani H., Limn C.K., Matsunaga T.M., Moriishi K., Matsuura Y. Ligand directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 2005, 79:3639-3652.
15. Oomens A.G., Blissard G.W. Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus. Virology 1999, 254:297-314.
16. Yang D.G., Chung Y.C., Lai Y.K., Liu H.J., Hu Y.C. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007, 15:989-996.
17. Xu X.G., Liu H.J. Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model. Vaccine 2008, 153:149-155.
18. Lin Y.H., Lee L.H., Shih W.L., Hu Y.C., Liu H.J. Baculovirus surface display of δC and δB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model. Vaccine 2008, 26:6361-6367.
19. Wang W.H., Zhang Y.M., Xu X.G., Xing F.S., Tang Q.H. Cloning and sequence analysis of the full-length genome of Japanese encephalitis virus strain SXBJ07 lsolated from swine. Agric Sci China 2009, 8:1392-1402.
20. Chen H.W., Pan C.H., Liua M.Y., Jou R., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese Encephalitis Virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999, 73:10137-10145.
21. Wu S.C., Yu C.H., Lin C.W., Chu I.M. The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity. Vaccine 2003, 21:2516-2522.
22. Chen H.W., Pan C.H., Liau M.Y., Jou R.W., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999, 73:10137-10145.
23. Kimura K.J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3(E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol 1983, 45:124-132.
24. Konishi E., Win K.S., Kurane I., Mason P.W., Shope R.E., Ennis F.A. Particulate vaccine candidate for Japanese encephalitis induces longlasting virus-specific memory T lymphocytes in mice. Vaccine 1997, 15:281-286.
25. Jan L.R., Yang C.S., Henchal L.S., Sumiyoshi H., Summers P.L., Dubois D.R., et al. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein. Am J Trop Med Hyg 1993, 48:412-413.
26. Konishi E., Pincus S., Paoletti E., Laegreid W.W., Shope R.E., Mason P.W. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 1992, 190:454-458.
27. Groner A., Granados R.R., Burand J.P. Interaction of Autographa californica nuclear polyhedrosis virus with two non-permissive cell lines. Intervirology 1984, 21:203-209.
28. Tjia S.T., Meyer zu Altenschildesche G., Doerfler W. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 1983, 125:107-117.
29. Konishi E., Yamaoka M., Khin S.W., Kurane I., Takada K., Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 1999, 73:5527-5534.
30. Hombach J., Solomon T., Kurane I., Jacobson J., Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2-3, 2004. Vaccine 2005, 23:5205-5211.
31. Kurane I., Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strain. Vaccine 2000, 18:33-35.
32. Konishi E., Pincus S., Paoletti E., Laegreid W.W., Shope R.E., Mason P.W. A highly attenuated host-range restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 1992, 190:454-458.
33. Konishi E., Mason P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol 1993, 67:1672-1675.
34. WenglerG, Wengler G. Cell-associated West Nile flavivirus is covered with E1pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol 1989, 63:2521-2526.
35. Mason P.W., Pincus S., Fournier M.J., Mason T.L., Shope R.E., Paoletti E. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 1991, 180:294-305.